Skip to main content
. 2022 Mar 9;17:123. doi: 10.1186/s13023-022-02264-2

Table 1.

Association of MTHFR rs1801133, CBS rs115742905, PT rs1799963, COL1A1 rs1107946 and rs2412298, COL2A1 rs121912891 and rs387906558 with Legg–Calvé–Perthes Disease

SNP and model Genotype Controls
n (%)
Cases
n (%)
OR (95% CI) p value# OR (95% CI)* p value*
MTHFR rs1801133
T/T 15 (32.6%) 6 (26.1%) 1.00 1.00
 Codominant C/T 21 (45.6%) 9 (39.1%) 1.07 (0.31–3.66) 0.43 (0.08–2.30)
C/C 10 (21.7%) 8 (34.8%) 2.00 (0.53–7.54) 0.51 3.69 (0.56–24.56) 0.07
 Dominant T/T 15 (32.6%) 6 (26.1%) 1.00 1.00
C/T-C/C 31 (67.4%) 17 (73.9%) 1.37 (0.45–4.19) 0.58 0.97 (0.23–3.99) 0.96
 Recessive T/T-C/T 36 (78.3%) 15 (65.2%) 1.00 1.00
C/C 10 (21.7%) 8 (34.8%) 1.92 (0.63–5.81) 0.25 5.62 (1.02–30.93) 0.038
CBS rs115742905
T/T 46 (100.0%) 23 (100.0%) Monomorphic SNP Monomorphic SNP
T/C 0 (0.0%) 0 (0.0%)
C/C 0 (0.0%) 0 (0.0%)
PT rs1799963
G/G 46 (100.0%) 23 (100.0%)
G/A 0 (0.0%) 0 (0.0%) Monomorphic SNP Monomorphic SNP
A/A 0 (0.0%) 0 (0.0%)
COL1A1 rs1107946
G/G 21 (45.6%) 13 (56.5%) 1.00 1.00
 Codominant G/T 13 (28.3%) 6 (26.1%) 0.75 (0.23–2.45) 0.63 0.73 (0.22–2.42)
T/T 12 ((26.1%) 4 (17.4%) 0.54 (0.14–2.03) 0.53 (0.14–2.00) 0.62
 Dominant G/G 21 (45.6%) 13 (56.51%) 1.00 1.00
G/T-T/T 25 (54.4%) 10 (43.5%) 0.60 (0.17–2.11) 0.41 0.63 (0.23–1.75) 0.38
 Recessive G/G-G/T 34 (73.9%) 19 (82.6%) 1.00 1.00
T/T 12 (26.1%) 4 (17.4%) 0.60 (0.17–2.11) 0.41 0.59 (0.17–2.10) 0.41
COL1A1 rs2412298
C/C 39 (84.8%) 19 (82.6%) 1.00 1.00
C/T 7 (15.2%) 4 (17.4%) 1.17 (0.31–4.50) 0.82 1.18 (0.31–4.55) 0.81
COL2A1 rs121912891
G/G 46 (100.0%) 23 (100.0%) Monomorphic SNP Monomorphic SNP
G/A 0 (0.0%) 0 (0.0%)
A/A 0 (0.0%) 0 (0.0%)
COL2A1 rs387906558
G/G 46 (100.0%) 23 (100.0%) Monomorphic SNP Monomorphic SNP
G/A 0 (0.0%) 0 (0.0%)
A/A 0 (0.0%) 0 (0.0%)

Significant values are shown in bold

*Adjusted by age

#Raw data